{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:09:34Z","timestamp":1784830174222,"version":"3.55.0"},"reference-count":42,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST NSTC 113-2314-B-182A-152"],"award-info":[{"award-number":["MOST NSTC 113-2314-B-182A-152"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the efficacy of current treatments for retinitis pigmentosa (RP)-associated macular oedema using network meta-analysis (NMA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Electronic databases were searched for studies reporting changes in best-corrected visual acuity (BCVA) and central macular thickness (CMT). A frequentist NMA was performed and treatment hierarchies were estimated using the surface under the cumulative ranking curve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>12 studies were included to compare the following: oral acetazolamide 500\u2009mg\/day, oral methazolamide 50\u2013100\u2009mg\/day, topical dorzolamide 2% three times daily, topical ketorolac 0.5% four times daily, intravenous umbilical cord mesenchymal stem cells (UCMSCs; single administration of 3\u00d710\u2076 cells), intravitreal dexamethasone implant (DEXi) 0.7 mg, intravitreal triamcinolone acetonide (IVTA) 4\u2009mg, sub-Tenon TA (STTA) 20\u2009mg, intravitreal bevacizumab 1.25\u2009mg and intravitreal ranibizumab 0.5\u2009mg. Regarding changes in BCVA at 3\u20134 months, oral carbonic anhydrase inhibitors (CAIs) showed greater BCVA improvement compared with anti-vascular endothelial growth factor (anti-VEGF) therapies; however, no intervention demonstrated statistically significant superiority in BCVA at 12 months. At 3\u20134 months, DEXi, acetazolamide, methazolamide and dorzolamide demonstrated comparable CMT reduction and outperformed anti-VEGF therapies, IVTA, STTA, intravenous UCMSC and control. By 12 months, dorzolamide (vs acetazolamide: \u2212169.50\u2009\u00b5m (95%\u2009CI \u2212331.83 to \u22127.17) and vs methazolamide: \u2212185.49\u2009\u00b5m (95%\u2009CI \u2212354.35 to \u221216.63)) and DEXi (vs acetazolamide: \u2212147.00\u2009\u00b5m (95%\u2009CI \u2212206.58 to \u221287.42) and vs methazolamide: \u2212162.99\u2009\u00b5m (95%\u2009CI \u2212238.56 to \u221287.42)) provided significantly greater CMT reduction than acetazolamide and methazolamide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CAIs and DEXi demonstrated the greatest long-term anatomical benefit for RP-associated macular oedema, whereas durable BCVA gains remained limited across available therapies. While oral and topical CAIs showed comparable short-term efficacy, topical dorzolamide and DEXi provided greater long-term CMT reduction than oral CAIs. Given the limited number of studies and small sample sizes, these findings should be interpreted cautiously and validated in larger randomised controlled trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2026-002896","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:50:19Z","timestamp":1784829019000},"page":"e002896","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of different treatment modalities in the management of macular oedema in retinitis pigmentosa: a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"11","author":[{"given":"Hsi-An","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Education, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"Graduate Institute of Biomedical Sciences, China Medical University, Taichung, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wun-Long","family":"Jheng","sequence":"additional","affiliation":[{"name":"Cancer Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-3234","authenticated-orcid":false,"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-7255","authenticated-orcid":false,"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-3059","authenticated-orcid":false,"given":"Hung-Da","family":"Chou","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-6530","authenticated-orcid":false,"given":"Eugene Yu-Chuan","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Ning","family":"Chao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ting","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Jen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2682-939X","authenticated-orcid":false,"given":"Yi-Hsing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026072310501139000_11.3.e002896.1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/IIO.0000000000000542","article-title":"Retinitis pigmentosa and therapeutic candidates","volume":"65","author":"Livingston","year":"2025","journal-title":"Int Ophthalmol Clin"},{"key":"2026072310501139000_11.3.e002896.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-022-01243-2"},{"key":"2026072310501139000_11.3.e002896.3","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1097\/IAE.0000000000003531","article-title":"Effect of oral carbonic anhydrase inhibitor on cystoid macular edema associated with retinitis pigmentosa: an OCT and OCT angiography study","volume":"42","author":"Yeo","year":"2022","journal-title":"Retina"},{"key":"2026072310501139000_11.3.e002896.4","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309376"},{"key":"2026072310501139000_11.3.e002896.5","doi-asserted-by":"crossref","DOI":"10.1186\/s40942-024-00608-7","article-title":"Self-reported visual function and in-depth swept-source optical coherence tomography features of cystoid macular edema in retinitis pigmentosa","volume":"10","author":"Costa","year":"2024","journal-title":"Int J Retina Vitreous"},{"key":"2026072310501139000_11.3.e002896.6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","article-title":"Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review","volume":"63","author":"Bakthavatchalam","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"2026072310501139000_11.3.e002896.7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oftal.2023.09.005","article-title":"Protocol for the treatment of cystoid macular edema secondary to retinitis pigmentosa and other inherited retinal dystrophies","volume":"99","author":"Catal\u00e0-Mora","year":"2024","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"2026072310501139000_11.3.e002896.8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.51329\/mehdiophthal1443","article-title":"Carbonic anhydrase inhibitors in the management of macular edema: A review of the literature","volume":"11","author":"Shahsuvaryan","year":"2022","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"2026072310501139000_11.3.e002896.9","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.185"},{"key":"2026072310501139000_11.3.e002896.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1583-7"},{"key":"2026072310501139000_11.3.e002896.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026072310501139000_11.3.e002896.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026072310501139000_11.3.e002896.13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jrsm.1373","article-title":"MetaInsight: An interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta","volume":"10","author":"Owen","year":"2019","journal-title":"Res Synth Methods"},{"key":"2026072310501139000_11.3.e002896.14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1477889","article-title":"Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa","volume":"15","author":"Liang","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026072310501139000_11.3.e002896.15","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.6.759"},{"key":"2026072310501139000_11.3.e002896.16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000368052","article-title":"Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher\u2019s syndrome","volume":"233","author":"Lemos Reis","year":"2015","journal-title":"Ophthalmologica"},{"key":"2026072310501139000_11.3.e002896.17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/jop.2018.0153","article-title":"Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa","volume":"36","author":"Veritti","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"2026072310501139000_11.3.e002896.18","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2009.0089"},{"key":"2026072310501139000_11.3.e002896.19","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199705000-00009"},{"key":"2026072310501139000_11.3.e002896.20","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15995"},{"key":"2026072310501139000_11.3.e002896.21","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070020519031"},{"key":"2026072310501139000_11.3.e002896.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(94)31277-2"},{"key":"2026072310501139000_11.3.e002896.23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/IAE.0000000000004039","article-title":"Dexamethasone implant versus topical carbonic anhydrase inhibitors in patients with bilateral retinitis pigmentosa-related cystoid macular edema: a prospective, paired-eye pilot study","volume":"44","author":"Colombo","year":"2024","journal-title":"Retina"},{"key":"2026072310501139000_11.3.e002896.24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.694225","article-title":"Comparative study of a modified sub-Tenon\u2019s capsule injection of triamcinolone acetonide and the intravenous infusion of umbilical cord mesenchymal stem cells in retinitis pigmentosa combined with macular edema","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026072310501139000_11.3.e002896.25","doi-asserted-by":"publisher","DOI":"10.1007\/s004170050175"},{"key":"2026072310501139000_11.3.e002896.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-27994-6","article-title":"Characterizing macular edema in retinitis pigmentosa through a combined structural and microvascular optical coherence tomography investigation","volume":"13","author":"Arrigo","year":"2023","journal-title":"Sci Rep"},{"key":"2026072310501139000_11.3.e002896.27","doi-asserted-by":"crossref","DOI":"10.1007\/s40135-025-00332-x","article-title":"Systemic carbonic anhydrase inhibitors in common ophthalmic diseases: a scoping review from a clinical standpoint","volume":"13","author":"Hallaj","year":"2025","journal-title":"Curr Ophthalmol Rep"},{"key":"2026072310501139000_11.3.e002896.28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/108076802760116133","article-title":"Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol","volume":"18","author":"Stewart","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"2026072310501139000_11.3.e002896.29","first-page":"6","article-title":"Long-term glaucoma treatment with MK-507, dorzolamide, a topical carbonic anhydrase inhibitor","volume":"4","year":"1995","journal-title":"J Glaucoma"},{"key":"2026072310501139000_11.3.e002896.30","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319530"},{"key":"2026072310501139000_11.3.e002896.31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.31083\/ph.2008.7322","article-title":"Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations","volume":"63","author":"Loftsson","year":"2008","journal-title":"Pharmazie"},{"key":"2026072310501139000_11.3.e002896.32","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.111.040055"},{"key":"2026072310501139000_11.3.e002896.33","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-303005"},{"key":"2026072310501139000_11.3.e002896.34","doi-asserted-by":"crossref","first-page":"1653404","DOI":"10.3389\/fopht.2025.1653404","article-title":"Ocular and systemic immune profiles associated with cystoid macular edema in retinitis pigmentosa","volume":"5","author":"Tao","year":"2025","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"2026072310501139000_11.3.e002896.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.006"},{"key":"2026072310501139000_11.3.e002896.36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051327","article-title":"The treatment of diabetic retinal edema with intravitreal steroids: how and when","volume":"13","author":"Salvetat","year":"2024","journal-title":"J Clin Med"},{"key":"2026072310501139000_11.3.e002896.37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00061198-199812000-00007","article-title":"Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group","volume":"7","author":"Adamsons","year":"1998","journal-title":"J Glaucoma"},{"key":"2026072310501139000_11.3.e002896.38","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-313991"},{"key":"2026072310501139000_11.3.e002896.39","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005785","article-title":"Structural analysis of retinal photoreceptor ellipsoid zone and postreceptor retinal layer associated with visual acuity in patients with retinitis pigmentosa by ganglion cell analysis combined with OCT imaging","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026072310501139000_11.3.e002896.40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00417-018-4185-4","article-title":"Outer retinal layers as predictors of visual acuity in retinitis pigmentosa: a cross-sectional study","volume":"257","author":"Sousa","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026072310501139000_11.3.e002896.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276629","article-title":"Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa","volume":"17","author":"Ruff","year":"2022","journal-title":"PLoS One"},{"key":"2026072310501139000_11.3.e002896.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296493","article-title":"Evaluation of photoreceptor features in retinitis pigmentosa with cystoid macular edema by using an adaptive optics fundus camera","volume":"19","author":"Kitahata","year":"2024","journal-title":"PLoS ONE"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2026-002896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:50:23Z","timestamp":1784829023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2026-002896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjophth-2026-002896"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2026-002896","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}